LARK Q1 2026 Earnings EPS of 083 Amidst Stock Decline CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances AGAI Q1 2025 Earnings Net Loss Persists as Esports Firm Positions for Growth Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline ARE Q1 2026 Earnings Massive EPS Surprise Driven by Strong Operational Performance BGS Q1 2026 Earnings Profit Beat Drives Caution Amid Revenue Disclosures